Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orly Vardeny

Showing results (41-50 of 168) with videos related to

Pageof 17
Sort By:
BMC Medicine|December 18, 2020
Cardiovascular implications of COVID-19 versus influenza infection: a reviewMuhammad Shahzeb Khan, Izza Shahid, Stefan D Anker, et al.
American Journal of Hypertension|June 1, 2012
β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprololOrly Vardeny, Gabriel Nicholas, Alina Andrei, et al.
Circulation. Heart Failure|August 14, 2013
Race influences the safety and efficacy of spironolactone in severe heart failureOrly Vardeny, Larisa H Cavallari, Brian Claggett, et al.
Journal of General Internal Medicine|August 22, 2020
Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysisHanna E Bloomfield, Nancy Greer, Amy M Linsky, et al.
The American Journal of Cardiology|April 22, 2011
Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery diseaseOrly Vardeny, Hajime Uno, Eugene Braunwald, et al.
European Journal of Heart Failure|April 16, 2020
Trends in prevalence of comorbidities in heart failure clinical trialsMuhammad Shahzeb Khan, Ayman Samman Tahhan, Muthiah Vaduganathan, et al.
JAMA Cardiology|March 28, 2019
Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities StudySonja Kytömaa, Sheila Hegde, Brian Claggett, et al.
JAMA Network Open|August 26, 2025
Geographic Disparities by Rural-Urban Status and Drive Time to Care in Tobacco Treatment for COPDArianne K Baldomero, Anne C Melzer, Ken M Kunisaki, et al.
Journal of the American Heart Association|June 18, 2025
Educational Attainment Level and Risk of Mortality and Cardiopulmonary Outcomes in High-Risk Patients With Cardiovascular Disease: The INVESTED TrialMats C H Lassen, Nicholas Howell, Brian L Claggett, et al.
Journal of Cardiac Failure|January 8, 2025
Predicted Mortality and Cardiology Follow-up Following Heart Failure Hospitalizations Among Veterans Health Administration PatientsRebecca L Tisdale, Fang Cao, Megan Skye, et al.
Pageof 17

Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
BMC Medicine|December 18, 2020
Cardiovascular implications of COVID-19 versus influenza infection: a reviewMuhammad Shahzeb Khan, Izza Shahid, Stefan D Anker, et al.
American Journal of Hypertension|June 1, 2012
β-AR polymorphisms and glycemic and lipid parameters in hypertensive individuals receiving carvedilol or metoprololOrly Vardeny, Gabriel Nicholas, Alina Andrei, et al.
Circulation. Heart Failure|August 14, 2013
Race influences the safety and efficacy of spironolactone in severe heart failureOrly Vardeny, Larisa H Cavallari, Brian Claggett, et al.
Journal of General Internal Medicine|August 22, 2020
Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysisHanna E Bloomfield, Nancy Greer, Amy M Linsky, et al.
The American Journal of Cardiology|April 22, 2011
Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery diseaseOrly Vardeny, Hajime Uno, Eugene Braunwald, et al.
European Journal of Heart Failure|April 16, 2020
Trends in prevalence of comorbidities in heart failure clinical trialsMuhammad Shahzeb Khan, Ayman Samman Tahhan, Muthiah Vaduganathan, et al.
JAMA Cardiology|March 28, 2019
Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities StudySonja Kytömaa, Sheila Hegde, Brian Claggett, et al.
JAMA Network Open|August 26, 2025
Geographic Disparities by Rural-Urban Status and Drive Time to Care in Tobacco Treatment for COPDArianne K Baldomero, Anne C Melzer, Ken M Kunisaki, et al.
Journal of the American Heart Association|June 18, 2025
Educational Attainment Level and Risk of Mortality and Cardiopulmonary Outcomes in High-Risk Patients With Cardiovascular Disease: The INVESTED TrialMats C H Lassen, Nicholas Howell, Brian L Claggett, et al.
Journal of Cardiac Failure|January 8, 2025
Predicted Mortality and Cardiology Follow-up Following Heart Failure Hospitalizations Among Veterans Health Administration PatientsRebecca L Tisdale, Fang Cao, Megan Skye, et al.
Pageof 17